Stock Alerts
Last Post: 06/26/2025 9:24:02 AM
Board Marks: 17
Posts Today: 0
Board Views Today: 95
11/01/2019 11:03:50 AM
10/31/2019 12:14:30 PM
10/30/2019 11:09:44 AM
10/30/2019 11:06:52 AM
10/29/2019 9:32:20 AM
10/28/2019 8:34:58 AM
10/28/2019 8:32:31 AM
10/25/2019 6:34:20 AM
10/24/2019 6:31:54 AM
10/23/2019 6:54:22 AM
10/22/2019 10:12:00 AM
10/21/2019 12:46:33 PM
10/21/2019 12:43:06 PM
10/18/2019 12:46:46 PM
10/17/2019 12:57:43 PM
10/17/2019 6:40:42 AM
10/17/2019 6:32:12 AM
10/16/2019 8:19:20 AM
10/15/2019 12:09:22 PM
10/15/2019 6:56:47 AM
10/14/2019 1:08:49 PM
10/14/2019 8:25:02 AM
10/11/2019 11:10:15 AM
10/10/2019 11:21:32 AM
10/09/2019 8:15:03 AM
10/07/2019 3:10:44 PM
10/04/2019 2:06:29 PM
10/03/2019 11:04:52 AM
10/02/2019 6:14:49 AM
10/01/2019 2:10:41 PM
09/30/2019 10:15:06 AM
09/26/2019 9:00:43 AM
09/24/2019 3:05:00 PM
09/24/2019 2:42:53 PM
09/23/2019 12:59:09 PM
09/23/2019 12:40:32 PM
09/20/2019 2:08:21 PM
09/20/2019 2:06:32 PM
09/19/2019 10:18:23 AM
09/19/2019 10:14:30 AM
09/18/2019 10:16:29 AM
09/17/2019 12:08:26 PM
09/17/2019 11:11:18 AM
09/16/2019 10:23:09 AM
09/13/2019 8:51:49 AM
09/13/2019 8:30:12 AM
09/12/2019 9:09:53 AM
09/11/2019 10:10:46 AM
09/10/2019 11:17:28 AM
09/09/2019 2:12:02 PM
Recent Articles
- Skanska's Major Investment in Sustainable Housing Development
- Understanding the Monthly Factsheet for Tetragon Financial
- Hansa Biopharma Offers Promising Insights on Imlifidase in Transplants
- Positive Five-Year Data on Imlifidase in Kidney Transplants
- Amaroq Minerals Closes Major Fundraising Effort
- Elis Enhances Shareholder Value Through Strategic Buybacks
- IMCD Expands Horizons with Acquisition of Apus Química
- KuCoin Thailand Partners with Finansia Syrus to Enhance Assets
- Understanding Aktsiaselts Infortar's Dividends and Operations
- AB Science Updates Loan Restructuring for Strategic Growth
- Haffner Energy Achieves Key Milestones in 2024-2025 Financial Year
- Skanska Commits CZK 1.6 Billion to Innovative Housing Project
- SWI Group Strengthens European Strategy with New Data Centre
- Tetragon Financial Group's Monthly Overview and Insights
- SWI Group's Innovative Data Centre Expansion in Europe
- MIMARU Introduces Enhanced Rooms to Enchant Pokemon Fans
- Klotho Neurosciences Advances Gene Therapy for ALS Patients
- KuCoin Thailand Partners with Finansia Syrus to Innovate Digital Assets
- Aker Solutions and Cognizant Team Up for IT Modernization
- IMCD Enhances Advanced Materials Solutions with Apus Química
- Infortar Announces Upcoming Dividend Payments for Shareholders
- Trifork Group's Commitment to Shareholder Value Through Buyback
- Revolutionary IoT Chip by CT Group Poised to Dominate Market
- Nextensa and Promobe Team Up for Eosys Development
- Sermatec and Foxconn Drive Innovation in Energy Storage Solutions
- The Bouzy Group Unveils New Coastal Lifestyle Investment Option
- Vallourec Enhances Collaboration with ADNOC Through Major Order
- Nextensa Advancing Footprint with Eosys Construction Project
- Endeavour Mining's Recent Share Buy-Back Program Highlights
- Celebrating 20 Years of Reddit: A Distinctive Social Media Journey
- Nicox Achieves Major Milestone in NCX 470 Clinical Trial
- Vallourec's Major Supply Order from ADNOC Signals Growth
- Sanofi Announces Release of Q2 2025 Aide Mémoire for Investors
- Fosun International's Accolades Highlight Corporate Excellence
- Exciting Progress: Nicox's NCX 470 Trial Nears Major Milestone
- Sanofi Unveils Release of Q2 2025 Financial Insights
- Totalkredit A/S Unveils Latest Prepayment Insights and Data
- Prepayment Trends and Insights from Nykredit Realkredit A/S
- Exciting Launch: White Castle's New Crispy Chicken Slider
- Idorsia's Innovative Vaccine Platform: A New Era in Medicine
- Addex Therapeutics Invests CHF 2 Million in Stalicla for CNS Innovation
- ARGX-119 Clinical Advancement: A New Era for CMS Treatment
- Roche Announces Leadership Changes in Executive Committee
- Riliprubart Receives Orphan Drug Designation in Japan for CIDP
- SEALSQ Corp Enhances Quantum Resilience through Investment in WECAN
- Riliprubart's Orphan Drug Designation: A Path to Innovation
- Advancements in ARGX-119 Clinical Trials for Myasthenic Syndromes
- Stalicla Secures Crucial Funding to Propel Neurodevelopmental Programs
- Oman Air Takes Flight into the Global Travel Scene
- PAP Devices Market Growth Outlook: Innovations and Demand Surge
